Related Experiment Videos
Listeria monocytogenes endophthalmitis: a case report
1Royal Hobart Hospital, New South Wales, Australia.
Australian and New Zealand Journal of Ophthalmology
|November 1, 1988
Abstract:
Listeria monocytogenes endophthalmitis is characterised by a progressively darkening indolent hypopyon. Gentamicin and amoxycillin, as used in this, the first reported Australian case, is the currently recommended treatment.
Insights
Listeria monocytogenes endophthalmitis causes a slowly worsening hypopyon. The recommended treatment involves gentamicin and amoxycillin, as demonstrated in Australia's first reported case.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Listeria monocytogenes is a significant bacterial pathogen.
- Endophthalmitis is a serious intraocular infection.
- Early diagnosis and treatment are crucial for vision preservation.
Observation:
- This report details the first Australian case of Listeria monocytogenes endophthalmitis.
- The clinical presentation included a progressively darkening, indolent hypopyon.
- The patient's condition was managed with a specific antibiotic regimen.
Findings:
- Listeria monocytogenes was identified as the causative agent.
- The observed hypopyon is characteristic of this specific type of endophthalmitis.
- Successful treatment was achieved using the recommended antimicrobial agents.
Implications:
- This case highlights the importance of recognizing Listeria monocytogenes endophthalmitis.
- The findings support the current recommended treatment protocols.
- This underscores the need for prompt antimicrobial therapy in suspected cases of endophthalmitis.